The changing face of the exocrine pancreas in cystic fibrosis: Pancreatic sufficiency, pancreatitis and genotype

European Journal of Gastroenterology and Hepatology

Volumn 20, Issue 3, 2008, Pages 157-160

  Walkowiak, Jarosław ^a,b   Lisowska, Aleksandra ^a   Blaszczyński, Michal ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Cystic fibrosis; Genotype; Pancreatic sufficiency; Pancreatitis

Indexed keywords

CYCLIC AMP; TRANSMEMBRANE CONDUCTANCE REGULATOR;

CYSTIC FIBROSIS; DISEASE COURSE; GENE MUTATION; GENOTYPE; HUMAN; PANCREAS FUNCTION; PANCREAS INSUFFICIENCY; PANCREAS SECRETION; PANCREATITIS; PRIORITY JOURNAL; REVIEW; STEATORRHEA;

CYSTIC FIBROSIS; EXOCRINE PANCREATIC INSUFFICIENCY; GENOTYPE; HUMANS; PANCREAS, EXOCRINE; PANCREATITIS;

EID: 39849106615     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3282f36d16     Document Type: Review

References (34)

1. Augarten A, Ben Tov A, Madgar I, Barak A, Akons H, Laufer J, et al. The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and CF genotype. Eur J Gastroenterol Hepatol 2008;20:164-168.
2. Bear CE, Li CH, Kartner N, Bridges RJ, Jensen TJ, Ramjeesingh E, Riordan JR. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell 1992; 68:809-819.
3. Kopelman H, Corey M, Gaskin K, Durie P,Weizman Z, Forstner G. Impaired chloride secretion, as well as bicarbonate secretion, underlies the fluid secretory defect in the cystic fibrosis pancreas. Gastroenterology 1988; 95:349-355.
4. Kopelman H, Durie P, Gaskin K, Weizman Z, Forstner G. Pancreatic fluid secretion and protein hyperconcentration in cystic fibrosis. N Eng J Med 1985; 312:329-334.
5. Scheele GA, Fukuoka S-I, Kern HF, Freedman SD. Pancreatic dysfunction in cystic fibrosis occurs as a result of impairments in luminal pH, apical trafficking of zymogen granule membranes, and solubilization of secretory enzymes. Pancreas 1996; 12:1-9.
6. Augarten A, Katznelson D, Dubenbaum L, Doolman R, Sela BA, Lusky A. Serum lipase levels pre and post Lundh meal: evaluation of exocrine pancreatic status in cystic fibrosis. Int J Clin Lab Res 1998; 28: 226-229.
7. Walkowiak J, Nousia-Arvanitakis S, Lisowska A, Piotrowski R, Strzykala K, Bychowiec B. Serum lipase secretin stimulation detect mild pancreatic involvement in cystic fibrosis. J Pediatr Gastroenterol Nutr 2004; 38: 430-435.
8. Kerem BS, Buchanan JA, Durie P, Corey ML, Levison H, Rommens JM. DNA marker haplotype association with pancreatic sufficiency in cystic fibrosis. Am J Hum Genet 1989; 44:827-834.
9. Borgo G, Mastella G, Gasparini P, Zorzanello A, Doro R, Pignatti PF. Pancreatic function and gene deletion F508 in cystic fibrosis. J Med Genet 1990; 27:665-669.
10. Kerem E, Kerem B. Genotype-phenotype correlations in cystic fibrosis. Pediatr Pulmonol 1996; 22:387-395.
11. Santis G, Osborne L, Knight RA, Hodson ME. Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis. Lancet 1990; 336:1081-1084.
12. Kristidis P, Bozon D, Corey M, Markiewicz D, Rommens J, Tsiu LC, Durie PR. Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet 1992; 50:1178-1184.
13. The Cystic Fibrosis Genotype-Phenotype Consortium. Correlation between genotype and phenotype in patients with cystic fibrosis. N Eng J Med 1993; 329:1308-1313.
14. Hubert D, Bienvenu T, Desmazes-Defeu N, Fajac I, Lacronique J, Matran R. Genotype-phenotype relationships in a cohort of adult cystic fibrosis patients. Eur Respir J 1996; 9:2207-2214.
15. Walkowiak J, Herzig KH, Witt M, Pogorzelski A, Piotrowski R, Barra E. Analysis of exocrine pancreatic function in cystic fibrosis: one mild CFTR mutation does not exclude pancreatic insufficiency. Eur J Clin Invest 2001; 31:796-801.
16. Durno C, Corey M, Zielenski J, Tullis E, Tsui LC, Durie P. Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. Gastroenterology 2002; 123:1857-1864.
17. Dray X, Marteau P, Bienvenu T, Dusser D, Hubert D. Discussion on genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. Gastroenterology 2003; 125:1286.
18. Walkowiak J, Nousia-Arvanitakis S, Henker J, Stern M, Sinaasappel M, Dodge JA. Indirect pancreatic function tests in children. J Pediatr Gastroenterol Nutr 2005; 40:107-114.
19. Borowitz D. Update on the evaluation of pancreatic exocrine status in cystic fibrosis. Curr Opin Pulm Med 2005; 11:524-527.
20. Walkowiak J, Herzig KH, Strzykala K, Przyslawski J, Krawczyñski M. Fecal elastase-1 is superior to fecal chymotrypsin in the assessment of pancreatic involvement in cystic fibrosis. Pediatrics 2002; 110:E7.
21. Walkowiak J, Lisowska A, Przyslawski J, Grzymislawsli M, Krawczyñski M, Herzig KH. Faecal elastase test is superior to faecal lipase test in the assessment of exocrine pancreatic function in cystic fibrosis. Acta Paediatr 2004; 93:1042-1045.
22. Walkowiak J, Cichy W, Herzig KH. Comparison of fecal elastase-1 determination with the secretin-cholecystokinin test in patients with cystic fibrosis. Scand J Gastroenterol 1999; 34:202-207.
23. Beharry S, Ellis L, Corey M, Marcon M, Durie P. How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease? J Pediatr 2002; 141:84-90.
24. De Boeck K,Weren M, Proesmans M, Kerem E. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype. Pediatrics 2005; 115:463-469.
25. Kerem B, Chiba-Falek O, Kerem E. Cystic fibrosis in Jews: frequency and mutation distribution. Gent Test 1997; 1:149-153.
26. Waters DL, Dorney SF, Gaskin KJ, Gruca MA, O'Halloran M, Wilcken B. Pancreatic function in infants identified as cystic fibrosis in a neonatal screening program. N Engl J Med 1990; 322:303-308.
27. Gaskin K, Waters D, Dorney S, Gruca M, O'Halloran M, Wilcken B. Assessment of pancreatic function in screened infants with cystic fibrosis. Pediatr Pulmonol 1991; 7 (Suppl):69-71.
28. Bronstein MN, Sokol RJ, Abman SH, Chatfield BA, Hammond KB, Hambidge KM. Pancreatic insufficiency, growth and nutrition in infants identified by newborn screening as having cystic fibrosis. J Pediatr 1992; 120:533-540.
29. Walkowiak J, Sands D, Nowakowska A, Piotrowski R, Zybert K, Herzig KH, Milanowski A. Early decline of pancreatic function in cystic fibrosis patients with class 1 or 2 CFTR mutations. J Pediatr Gastroenterol Nutr 2005; 40:199-201.
30. Walkowiak J, Nousia-Arvanitakis S, Agguridaki C, Fotoulaki M, Strzykala K, Balassopoulou A. Longitudinal follow-up of exocrine pancreatic function in pancreatic sufficient cystic fibrosis patients with the use of fecal elastase-1 test. J Pediatr Gastroenterol Nutr 2003; 36:474-478.
31. Littlewood JM,Wolfe SP, Firth J, Brownlee KG, Conway SP, Littlewood JM. Control of malabsorption in cystic fibrosis. Paediatr Drugs 2000; 2:205-222.
32. Walkowiak J. Fecal elastase-1 test: clinical value in the assessment of exocrine pancreatic function in children. Eur J Pediatr 2000; 159:869-870.
33. Cade A, Walters MP, McGinley N, Firth J, Brownlee KG, Conway SP, Littlewood JM. Evaluation of fecal pancreatic elastase-1 as a measure of pancreatic exocrine function in children with cystic fibrosis. Pediatr Pulmonol 2000; 29:172-176.
34. Wilschanski M, Durie P. Patterns of GI disease in adulthood associated with mutation in the CFTR gene. Gut 2007; 56:1153-1166.